CS
NUVB icon

Candriam SCA’s Nuvation Bio NUVB Stock Holding History

Candriam SCA’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-140,129
Closed -$314K – 884
2022
Q3 		$314K Sell
140,129
-180,835
-56% -$516K ﹤0.01% 850
2022
Q2 		$1.04M Hold
320,964
– – 0.01% 620
2022
Q1 		$1.69M Buy
320,964
+25,029
+8% +$141K 0.01% 579
2021
Q4 		$2.52M Buy
295,935
+8,836
+3% +$81.2K 0.02% 501
2021
Q3 		$2.85M Buy
+287,099
New +$2.6M 0.02% 507

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Candriam SCA's NUVB Position: Q4 2022 in Review

Candriam SCA sold out of Nuvation Bio (NUVB) in Q4 2022, closing a stake of 140,129 shares — an estimated $314K sold.

Candriam SCA first reported a position in NUVB in Q3 2021 and held it in 5 quarters. The position peaked at $2.85M in Q3 2021. 126 funds tracked by Wall St. Rank hold NUVB as of Q4 2022.

  • Candriam SCA reported no remaining Nuvation Bio position as of Q4 2022 after selling out during the quarter.
  • Candriam SCA sold 140,129 Nuvation Bio shares in Q4 2022, an estimated $314K.
  • Candriam SCA first reported a position in Nuvation Bio in Q3 2021 and held it in 5 quarters.
  • Candriam SCA's Nuvation Bio position peaked at $2.85M in Q3 2021.
  • 126 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2022.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.